Lyophilized compounds produced via modern microwave-assisted SPPS, complete with individual lot-specific HPLC chromatograms and Mass Spectrometry validation for metabolic and cellular pathway assays in Doha.
Lyophilized metabolic peptide sequence synthesized for high-affinity receptor binding and endocrine metabolic mechanism studies across GCC university labs.
Incretin mimetic peptide controls featuring verified secondary amide linkage structure, designed for diabetes research and lipid regulatory modeling.
Advanced research peptide portfolio incorporating multi-receptor GIP/GLP-1/GCGR agonists for preclinical adipose tissue apoptosis and metabolic pathway analysis.
Factory-direct bulk packaging for contract research organizations and scientific labs requiring scalable multi-gram or multi-vial stability across Doha.
Under the framework of the Qatar National Vision 2030 (QNV 2030), Doha has rapidly transformed from a regional commerce center into a world-class biomedical research capital. Driven by massive capital allocations into precision medicine, genomic mapping, and metabolic disorder interventions, the demand for ultra-pure synthetic peptides is surging.
Doha's biomedical ecosystem is anchored by flagship institutions including Weill Cornell Medicine-Qatar, Sidra Medicine, and Hamad bin Khalifa University (HBKU). Research laboratories in Education City focus extensively on non-communicable disease genetics, requiring synthetic signaling peptides with strict endotoxin and stereoisomeric controls for in vitro and in vivo models.
The Gulf Cooperation Council (GCC) region faces significant public health challenges regarding Type 2 Diabetes (T2D), obesity, and metabolic syndrome. In response, biomedical initiatives across Hamad Medical Corporation (HMC) and the Qatar Precision Health Institute (QPHI) prioritize metabolic receptor agonists (GLP-1, GIP, Glucagon mimetics), creating ongoing need for batch-certified reference compounds.
Beyond academic research, Doha's private healthcare sector in Lusail, The Pearl-Qatar, and West Bay has embraced anti-aging medicine, regenerative dermatology, and cellular wellness therapies. This sector demands cosmetic hexapeptides, copper peptide complexes (GHK-Cu), and bioregulatory peptides manufactured under rigorous contamination-free sterile regimes.
Global peptide procurement has evolved past middleman distributors. Leading laboratories in Qatar partner directly with our specialized Chinese synthesis factories to secure chemical batch stability, complete analytical transparency, and substantial economy of scale.
Our manufacturing facility harnesses automated microwave-assisted Solid-Phase Peptide Synthesis (Fmoc/tBu chemistry), minimizing deletion sequences and truncated peptide impurities even on challenging long sequences (30–45 amino acids, such as Semaglutide, Tirzepatide, and Retatrutide). By optimizing coupling agents (HATU, HBTU, DIC/OxymaPure), we achieve reaction completion rates exceeding 99.8% per residue.
Crude peptides undergo multi-stage purification using industrial-scale Preparative Reverse-Phase High-Performance Liquid Chromatography (Prep-HPLC) with dynamic axial compression columns. For clinical and cell culture research, our facility offers counter-ion exchange, replacing harsh trifluoroacetate (TFA) salts with physiological acetate or hydrochloride formats to preserve experimental cellular viability.
Peptide stability heavily depends on the final lyophilization cycle. Our cleanroom freeze-drying facilities employ computer-controlled shelf temperature cooling, primary sublimation under precise vacuum, and secondary desorption. This process ensures cake morphology, minimal residual moisture (<3.0%), and immediate, crystal-clear reconstitution without aggregation upon adding sterile bacteriostatic water.
Every lot dispatched to the Doha market is accompanied by an immutable, batch-specific Certificate of Analysis (COA). We provide High-Performance Liquid Chromatography (RP-HPLC) chromatograms verifying purity, Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF confirming target molecular weight, Karl Fischer water titration, and net peptide content assay via amino acid analysis (AAA).
The peptide research industry is undergoing an unprecedented renaissance. The shift from classical replacement peptides toward engineered multi-receptor mimetics and targeted conjugates represents one of the most commercially lucrative and scientifically profound revolutions in modern therapeutics.
While mono-GLP-1 receptor agonists established the foundation of metabolic research, modern exploration centers on dual (GLP-1/GIP, such as Tirzepatide) and triple co-agonists (GLP-1/GIP/Glucagon, such as Retatrutide). These synthetic peptides demand meticulous chiral purity to mirror native tertiary receptor binding without eliciting off-target cross-reactivity.
Research programs at Qatari universities are heavily investigating mitochondrial-derived peptides like MOTS-c and Humanin, alongside telomere-associated pineal peptides like Epithalon. These molecules regulate insulin sensitivity at the muscular level, modulate oxidative stress pathways, and influence cellular senescence mechanisms.
Modern peptide engineering heavily integrates chemical modifications, including alpha-aminoisobutyric acid (Aib) substitutions to block DPP-4 enzymatic degradation, diacid fatty acylation (such as C18 or C20 fatty acid chains via gamma-Glu linkers) for reversible serum albumin binding, and site-specific PEGylation.
Importing synthetic biomolecules into the state of Qatar requires addressing specific operational challenges: extreme ambient summer temperatures exceeding 45°C, rigorous customs compliance by the Ministry of Public Health (MOPH), and prompt local distribution across Doha's institutional hubs.
Peptide peptide bonds and tertiary configurations are sensitive to heat and moisture. Shipments destined for Doha are packaged using VIP (Vacuum Insulated Panels), pre-conditioned phase-change materials (PCM), and temperature data-loggers calibrated for -20°C or 2°C–8°C transit, safeguarding integrity from our cleanroom through arrival at Hamad International Airport (DOH).
Leading academic laboratories in Education City require exact sequence fidelity to avoid misleading binding assay results. We provide peptide solutions calibrated for receptor binding affinity studies (Ki, EC50 determination), cell signaling cascades (cAMP, beta-arrestin recruitment), and pharmacokinetic (PK/PD) profiling in rodent animal models.
For research consortia and private diagnostic institutions in Doha, we provide contract lyophilization in custom vial formats (2ml, 3ml, 5ml, 10ml borosilicate glass), custom batch labeling, tamper-evident seals, and nitrogen-flushed atmospheres to ensure a minimum shelf-life of 24 to 36 months under standard refrigerated storage.
Our quality management architecture guarantees that every vial shipped to Doha research entities adheres to measurable chemical parameters, eliminating batch-to-batch variation.
Verification of starting resins (CTC, Wang, Rink Amide) and protected Fmoc amino acids by chiral HPLC to ensure optical purity and zero D-amino acid contamination.
Microwave-assisted automated solid-phase assembly with real-time UV monitoring of Fmoc deprotection to eliminate incomplete acylation cycles.
Controlled trifluoroacetic acid (TFA) cocktail cleavage with specialized scavengers (EDT, TIS, phenol) to suppress oxidation of methionine, tryptophan, and cysteine.
Primary purification on C18 stationary phase followed by secondary fine-gradient chromatography to isolate monomeric target peptides from stereoisomers.
Sterile 0.22-micron filtration, volumetric automated vial filling, Class A laminar flow freeze-drying, nitrogen purging, and automated hermetic crimp sealing.
Explore our core stock of metabolic peptides, synthetic secretagogues, growth hormone-releasing hormone analogues, and bioregulatory research compounds available for direct import to Doha.
Stabilized lyophilized powder for longitudinal metabolic energy expenditure and visceral fat lipolysis studies in lab models.
Supplied with independent third-party analytical testing, ensuring absolute identity confirmation for clinical academic projects.
Multi-target incretin peptide sequence engineered for preclinical glucagon pathway activation and hepatic steatosis research.
Recombinant 191-amino acid polypeptide reference compound for cellular regeneration, somatopause, and endocrine research.
Custom specification vial packaging offering rapid delivery schedules tailored for ongoing metabolic clinical trials.
Tetrasubstituted peptide analogue with Drug Affinity Complex (DAC) bioconjugated for prolonged plasma half-life investigations.
Comprehensive multi-scale vial sets with full mass spectral data, supporting endocrine pituary signaling research in institutional labs.
Potent synthetic hexapeptide ghrelin-receptor agonist widely deployed in cardiovascular and neuroendocrine pathway research models.
Procuring synthetic research peptides requires analytical expertise. Below is the operational framework required by institutional compliance teams before approving chemical suppliers.
A lyophilized vial labeled 10mg of peptide does not contain 10mg of pure active sequence. Moisture, residual counter-ions (such as TFA or acetate), and counter-cation salts often make up 20% to 30% of total powder weight. We clearly state Net Peptide Content via quantitative amino acid analysis (AAA), enabling exact molar dilution for research accuracy.
Racemization during coupling can introduce D-amino acid stereoisomers that share identical molecular weight with the target peptide, deceiving ordinary single-quadrupole mass spectrometers. Our QC laboratory employs chiral chromatographic assays to ensure that optical isomer contamination remains well under 0.5%.
Peptide synthesis utilizes reagents including dichloromethane (DCM), dimethylformamide (DMF), and piperidine. Our final purification incorporates headspace gas chromatography (GC) to verify that residual solvents meet ICH Q3C limits, and ICP-MS testing to confirm heavy metal limits (lead, arsenic, mercury, cadmium) < 1 ppm.
Everything procurement specialists, laboratory PIs, and commercial distributors in Qatar need to know regarding shipping, documentation, shelf-life, and testing protocols.
We use multi-layer thermal packaging combining vacuum insulation panels (VIP) and engineered phase change materials (PCM) or dry ice blocks. Each package includes an active USB/NFC temperature data-logger that monitors transit temperatures from export through final delivery at Hamad International Airport and the consignee's laboratory.
Every batch includes an official Certificate of Analysis (COA) containing RP-HPLC chromatograms, ESI-MS or MALDI-TOF mass spectra, Karl Fischer water titration results, solubility test sheets, and an SDS (Safety Data Sheet). Commercial invoices with exact HS codes (typically 2937 or 2933) are provided to ensure smooth customs clearance through Qatari regulatory checkpoints.
Yes. While standard solid-phase cleavage yields trifluoroacetate (TFA) salts, we offer preparative ion-exchange chromatography to convert peptides to acetate or hydrochloride forms. This is essential for cell culture assays, in vivo preclinical models, or cosmetic compounding where TFA cytotoxicity cannot be tolerated.
For catalog peptide vials, our MOQ starts from 10 vials. For custom sequence synthesis or bulk API orders, our capacity ranges from 10 milligrams (mg) for pilot screening to multi-kilogram (kg) commercial production, accommodating academic labs and industrial formulators alike.
Lyophilized peptide vials should be stored desiccated at -20°C for long-term stability (up to 36 months). For immediate daily use, reconstituted solutions using sterile bacteriostatic water should be kept at 2°C–8°C and used within 21 to 30 days. Avoid repeated freeze-thaw cycles by aliquoting solutions upon reconstitution.
We accept international wire transfers (T/T via SWIFT), confirmed Letters of Credit (L/C) for institutional contracts, and secure Escrow services. Verified university procurement offices and corporate accounts in Doha can apply for net-30 terms following initial trade history verification.
Partner directly with a certified synthesis manufacturer. Accelerate your research timeline with lot-certified chemical purity, compliant export documentation, and dedicated cold-chain air freight straight to your facility.
